The majority of cancer studies have shown that LGR5 was associated with WNT/β-catenin signaling, which increases the expression of target genes like E-cadherin (cell adhesion marker) via EMT, enhancing tumor adhesion. This evidence concerns the gene LGR5 and cancer.